CARNITOR

This brand name is authorized in United States. It is also authorized in Canada, Estonia, Hong Kong SAR China, UK.

Active ingredients

The drug CARNITOR contains one active pharmaceutical ingredient (API):

1	L-carnitine UNII 0G389FZZ9M - LEVOCARNITINE
	Levocarnitine as a factor is necessary in the transport of long-chain fatty acids into the mitochondria-facilitating the oxidation of fatty acids rather than their incorporation into triglycerides.
	Read more about L-carnitine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CARNITOR Tablet / Oral solution	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A16AA01	Levocarnitine	A Alimentary tract and metabolism → A16 Other alimentary tract and metabolism products → A16A Other alimentary tract and metabolism products → A16AA Amino acids and derivatives
Discover more medicines within A16AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02144328, 02144336, 02144344
EE	Ravimiamet	1746176
GB	Medicines & Healthcare Products Regulatory Agency	172879, 381247, 45347, 91536
HK	Department of Health Drug Office	39342, 41015
US	FDA, National Drug Code	54482-144, 54482-145, 54482-147, 54482-148